San Diego-based Viking Therapeutics marked by itself as a significant competitor within the weight loss drug sector in February soon after revealing promising details from the mid-phase demo of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when given as being a weekly injection and in March the company … Read More